Given the relationship between stress and depression, and the putative dysregulation of neuroplasticity in MDD patients, it has been hypothesized that effective antidepressant treatment requires an ability to modulate cellular neuroplasticity (Duman et al., 1999), which may include Arc expression. This evidence concerns the gene ARC and depressive symptom measurement.